Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses
- PMID: 17002989
- DOI: 10.1080/10826080600846235
Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses
Abstract
The liver disease characteristic of alcohol dependence encompasses three main related entities: steatosis, alcoholic hepatitis, and cirrhosis. Alcoholic cirrhosis is a leading cause of global morbidity and mortality. Alcohol intake among injecting drug users is a major contributor to transmission of viral infections, such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C viruses (HCV). HIV and HCV coinfected patients develop liver diseases earlier and more severely than the monoinfected individuals, including hepatocellular carcinoma. Interactions exist between the therapeutic drugs used to minimize and control the drug and alcohol dependence. Furthermore, drug-drug interactions occur between the highly active antiretroviral therapy (HAART) and alcohol, different HAART components and methadone, or each one of the therapies with the other, thus contributing to a higher toxicity level. With the evolution of effective antiretroviral therapy, survival of persons with HIV, and the syndrome it causes, acquired immunodeficiency syndrome (AIDS) has increased dramatically. Drug-drug interactions may appear between alcohol and anti-HBV or anti-HCV, therapy in the presence or absence of anti-HIV therapy. Several other medical-, social-, and drug-related factors of this population have to be considered when providing HAART. Because many coinfected patients also have problems with substance use, dealing with their drug dependence is an important first step in an attempt to improve adherence to and tolerance of antiviral therapy. It is necessary to minimize the risk of liver disease acceleration and/or reinfection with hepatitis viruses. Knowledge of potential drug interactions between methadone, antiretroviral therapy, psychoactive drugs, and antipsychotics and the role of coinfection with HBV or HCV and the drugs used in eradicating viral hepatitis permits suitable antiretroviral combinations.
Similar articles
-
Treating hepatitis C in HIV-HCV coinfected patients.Infection. 2002 Oct;30(5):329-31. Infection. 2002. PMID: 12420736
-
Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47. Trop Gastroenterol. 2008. PMID: 19115605 Review.
-
HIV and hepatitis C coinfection.J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.
-
Management of chronic hepatitis B and C in HIV-coinfected patients.J Antimicrob Chemother. 2006 May;57(5):815-8. doi: 10.1093/jac/dkl068. Epub 2006 Mar 23. J Antimicrob Chemother. 2006. PMID: 16556638
-
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.Clin Infect Dis. 2003 Feb 1;36(3):363-7. doi: 10.1086/345953. Epub 2003 Jan 14. Clin Infect Dis. 2003. PMID: 12539079
Cited by
-
Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.Biomedicines. 2020 Mar 18;8(3):63. doi: 10.3390/biomedicines8030063. Biomedicines. 2020. PMID: 32197424 Free PMC article. Review.
-
Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance Use Disorders.Fed Pract. 2018 Mar;35(Suppl 2):S14-S23. Fed Pract. 2018. PMID: 30766391 Free PMC article.
-
Molecular and contextual markers of hepatitis C virus and drug abuse.Mol Diagn Ther. 2009;13(3):153-79. doi: 10.2165/01250444-200913030-00002. Mol Diagn Ther. 2009. PMID: 19650670 Free PMC article. Review.
-
Alcoholic and non-alcoholic steatohepatitis.Exp Mol Pathol. 2014 Dec;97(3):492-510. doi: 10.1016/j.yexmp.2014.09.005. Epub 2014 Sep 11. Exp Mol Pathol. 2014. PMID: 25217800 Free PMC article. Review.
-
Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.AIDS Behav. 2017 Jul;21(7):1938-1949. doi: 10.1007/s10461-017-1769-7. AIDS Behav. 2017. PMID: 28421353 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical